| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |